GLP-1 Providers in Rhode Island (2026)

169 sellers list Rhode Island as a shipping state. The lowest regular price among them is $64/mo, and Rhode Island Medicaid weight-loss coverage ends October 2026.

169 sellersfrom $64/moMedicaid weight-loss coverage ends October 2026

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

169 of the 238 sellers that publish a state list include Rhode Island, the 42nd-most of the 50 states and DC. 128 of them ship to all 50 states. Across the 142 with a regular monthly price, the middle figure is $175/mo.

Rhode Island Medicaid still covers GLP-1 drugs for weight loss with prior authorization, but that coverage ends in October 2026. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Featured Partners · Rhode Island

Featured GLP-1 providers serving Rhode Island

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

  1. Top pick

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  2. Compounded from

    $112/mo

    Save $1,237/mo vs Wegovy
    Get started →
  3. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 6.7

    Compounded from

    $189/mo

    Save $1,160/mo vs Wegovy
    Get started →
  6. Compounded from

    $79/mo

    Save $1,270/mo vs Wegovy
    Get started →

Who Ships GLP-1s to Rhode Island

  1. RxPepsDirect $64/mo
  2. Embody $79/mo
  3. Lean Meds $79/mo

Lowest regular prices for Rhode Island: RxPepsDirect at $64/mo, Embody at $79/mo and Lean Meds at $79/mo.

12 sellers that list 30 or more states leave Rhode Island off, among them Rebody Health, Allara Health, DoctorAdam, Gatlan and Mixx Health & Wellness.

Seller counts next door: Connecticut 181 and Massachusetts 174.

Browse by medication

Rhode Island Medicaid and GLP-1 Coverage

Rhode Island Medicaid still covers GLP-1 drugs for weight loss with prior authorization, but that coverage ends in October 2026. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Prior authorization
Prior authorization formPA Form #PA04, Weight Management (EOHHS)
Prior authorization fax1-401-784-3889
Pharmacy benefit managerEOHHS FFS PDL; NHPRI + UHC MCO PBMs
Health plans (2)Neighborhood Health Plan of Rhode Island (NHPRI); UnitedHealthcare of New England (UHC)
Enrollmentabout 303,351 people (September 2025)
If the request is denied
Time to file an appeal30 days
Appeals officeEOHHS Appeals Office
Appeals phone(855) 840-4774
Rule that governs it210-RICR-10-05-2
Fast-track appealavailable when waiting would put your health at risk
“adopted a policy change that limits Medicaid coverage of glucagon-like peptide-1 (GLP-1)-based medications to only individuals with type 2 diabetes”
American Diabetes Association press release, 25 June 2026

In 2025, Rhode Island Medicaid paid for at least 46,691 GLP-1 prescriptions, including 21,489 for Ozempic, at least 6,899 for Wegovy, at least 6,951 for Mounjaro and at least 5,636 for Zepbound, about $48.9 million before manufacturer rebates. Drugs labeled for weight loss made up 31% of that spending.

Medicaid rules checked August 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Rhode Island

Rhode Island has 102 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 9.17 per 100,000 residents (20th of 51). By specialty: 48 bariatric, 54 endocrinology and 3 obesity medicine. About 31.1% of adults here had obesity in 2024 (CDC), the 38th-highest rate of the 50 states and DC. Measured against the median state, Rhode Island has 0.84 times as much adult obesity per specialist practice.

Every GLP-1 Provider Serving Rhode Island

9.4/ 10
Verified partner

Trimi Health

Best for: knowing which pharmacy fills the vial: it names VialsRx

★★★★★4.7/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Trimi Health review →
9.0/ 10
Verified partner

CoreAge Rx

Best for: semaglutide at $99/month, 48% below the typical price

★★★★★4.5/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
9.0/ 10
Verified partner

bmiMD

Best for: starting below a standard dose, with microdose tiers

★★★★★4.5/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →
9.0/ 10
Verified partner

Live Vital

Best for: semaglutide at $99/month, 48% below the typical price

★★★★★4.5/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideRetatrutideBPC-157
Get StartedRead full Live Vital review →
8.7/ 10
Verified partner

Gala

Best for: moving between compounded and brand without changing seller

★★★★☆4.4/5

Editorial score · methodology

$129/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Gala review →
Open the full A–Z list of 169 providers in Rhode Island

312 more sellers publish no state list

Their signup form tells you whether they ship to Rhode Island.

5.7/ 10
Verified partner

HumeCare+

Best for: an oral route if you will not self-inject

★★★☆☆2.9/5

Editorial score · methodology

$199/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full HumeCare+ review →
6.5/ 10
Verified partner

Sesame Care

Best for: oral orforglipron alongside the injectables

★★★☆☆3.3/5

Editorial score · methodology

$59/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
8.4/ 10
Verified partner

Collective

Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top

★★★★☆4.2/5

Editorial score · methodology

$59/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
7.7/ 10
Verified partner

HealthRX

Best for: compounded semaglutide at $133/month

★★★★☆3.9/5

Editorial score · methodology

$133/mo
SemaglutideTirzepatide
Get StartedRead full HealthRX review →
7.3/ 10
Verified partner

RNK Health

Best for: an oral route if you will not self-inject

★★★★☆3.7/5

Editorial score · methodology

$197/mo
CompoundedSemaglutideTirzepatideNAD+Sermorelin
Get StartedRead full RNK Health review →
5.9/ 10
Verified partner

SkinnyRx

Best for: starting below a standard dose, with microdose tiers

★★★☆☆3/5

Editorial score · methodology

$149.25/mo
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full SkinnyRx review →

Largest Cities in Rhode Island

ProvidenceWarwickCranstonPawtucket

Frequently Asked Questions

The lowest regular prices from sellers that ship to Rhode Island are $64/mo at RxPepsDirect, $79/mo at Embody and $79/mo at Lean Meds. Half of the 142 priced sellers charge $175/mo or less.
Rhode Island Medicaid still covers GLP-1 drugs for weight loss with prior authorization, but that coverage ends in October 2026. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.
Your prescriber sends the request on this paperwork: PA Form #PA04, Weight Management (EOHHS). Pharmacy claims run through EOHHS FFS PDL; NHPRI + UHC MCO PBMs.
A denial can be appealed within 30 days through the EOHHS Appeals Office ((855) 840-4774). A fast-track appeal is available when waiting would put your health at risk.
169, counting sellers whose published state list includes Rhode Island. 128 of those list every state. For comparison, Connecticut has 181 and Massachusetts has 174.
Rebody Health (47 states), Allara Health (44 states), DoctorAdam (44 states), Gatlan (44 states), Mixx Health & Wellness (44 states) and Superpower (42 states) publish long state lists that leave Rhode Island out.
In 2025, Rhode Island Medicaid paid for at least 46,691 GLP-1 prescriptions, including 21,489 for Ozempic, at least 6,899 for Wegovy, at least 6,951 for Mounjaro and at least 5,636 for Zepbound, about $48.9 million before manufacturer rebates. Drugs labeled for weight loss made up 31% of that spending.
Rhode Island has 102 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 9.17 per 100,000 residents (20th of 51). By specialty: 48 bariatric, 54 endocrinology and 3 obesity medicine. About 31.1% of adults here had obesity in 2024 (CDC), the 38th-highest rate of the 50 states and DC. Measured against the median state, Rhode Island has 0.84 times as much adult obesity per specialist practice.

Rankings: semaglutide providers · tirzepatide providers · clinical-trial results · GLP-1 pipeline

Glossary

The words sellers use, defined. Tap any term.